Drug Metabolism and Pharmacokinetics

Title Publication Date Language Citations
Xenobiotic-Metabolizing Enzymes Involved in Activation and Detoxification of Carcinogenic Polycyclic Aromatic Hydrocarbons2006/01/01English424
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans2009/01/01English372
Albumin as Fatty Acid Transporter2009/01/01English309
Organ/body-on-a-chip based on microfluidic technology for drug discovery2018/02/01English279
Tissue-specific mRNA Expression Profiles of Human ATP-binding Cassette and Solute Carrier Transporter Superfamilies2005/01/01English275
Human Carboxylesterase Isozymes: Catalytic Properties and Rational Drug Design2006/01/01English271
Metformin is a Superior Substrate for Renal Organic Cation Transporter OCT2 rather than Hepatic OCT12005/01/01English269
A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates2009/01/01English263
Lessons from the Crystallographic Analysis of Small Molecule Binding to Human Serum Albumin2009/01/01English229
Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies2005/01/01English195
Metabolism of Tacrolimus (FK506) and Recent Topics in Clinical Pharmacokinetics2007/01/01English187
Tissue-Specific mRNA Expression Profiles of Human Phase I Metabolizing Enzymes Except for Cytochrome P450 and Phase II Metabolizing Enzymes2006/01/01English172
Molecular Aspects of Renal Handling of Aminoglycosides and Strategies for Preventing the Nephrotoxicity2004/01/01English170
A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development2015/02/01English170
A Molecular Functional Study on the Interactions of Drugs with Plasma Proteins2005/01/01English170
Drug-Metabolizing Ability of Molybdenum Hydroxylases2006/01/01English156
Nuclear Receptor-Mediated Transcriptional Regulation in Phase I, II, and III Xenobiotic Metabolizing Systems2006/01/01English154
Solubility and Dissolution Profile Assessment in Drug Discovery2007/01/01English146
Regulation of Hepatocyte Nuclear Factor 4α-mediated Transcription2008/01/01English146
Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies2004/01/01English144
In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney2009/01/01English143
Receptor Occupancy-based Analysis of the Contributions of Various Receptors to Antipsychotics-induced Weight Gain and Diabetes Mellitus2005/01/01English134
Tissue-specific mRNA Expression Profiles of Human Solute Carrier Transporter Superfamilies2008/01/01English134
The Organic Anion Transporter (OATP) Family2004/01/01English132
Ethnic Differences in Genetic Polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB12004/01/01English118
Multiplicity of Mammalian Reductases for Xenobiotic Carbonyl Compounds2006/01/01English117
In Silico Approaches for Predicting ADME Properties of Drugs2004/01/01English117
Cancer Prevention by Natural Compounds2004/01/01English111
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs2021/12/01English107
Role of Human Hepatocyte Nuclear Factor 4α in the Expression of Drug-Metabolizing Enzymes and Transporters in Human Hepatocytes Assessed by Use of Small Interfering RNA2007/01/01English107